VolitionRX Ltd (NYSE MKT:VNRX) Q2 2020 Earnings Conference Call - Preliminary Transcript

Aug 14, 2020 • 08:30 am ET


VolitionRX Ltd (NYSE MKT:VNRX) Q2 2020 Earnings Conference Call - Preliminary Transcript


Loading Event

Loading Transcript


Good morning, ladies and gentlemen, and thank you for standing by, welcome to VolitionRx Limited's Second Quarter 2020 earnings conference call. During today's presentation all participants will be in a listen-only mode. Following the presentation, the conference call will be opened for questions. If you have a question please press the star key followed by the number one on your touch tone phone if you would like to withdraw, your question please press the star key followed by the number 2, if you are using speaker equipment please lift the handset before making your selections. This conference call is being recorded. August 14 2020. I would now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead.

Scott Powell

Thank you. And welcome everyone to todays earnings conference call for VolitionRx Limited. This call will cover Volition's financial and operating results for the second quarter of 2020 along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks we will open the conference call to a question and answer session.Also on our call today. Mr Cameron Reynolds, President and Chief Executive Officer and Mr David Vanston Chief Financial Officer.

Before we begin I'd like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 these statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events these statements involve risks, uncertainties and assumptions.

Actual future results may vary significantly based on a number of factors that may cause the actual results or events to be materially different from future results, performance or achievements expressed or implied by these statements. We have identified various risk factors associated with our operations in our most recent Annual Report on Form 10-K, quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission. We do not undertake an obligation to update any forward-looking statements made during this call.

I'd now like to turn the call over to our President and Chief Executive Officer, Mr Cameron Reynolds Cameron

Mr Cameron Reynolds

Thank you everyone for joining Volitions conference call today. I especially appreciate it. Given the busy earnings call season and the ongoing pandemic speaking leverage let us first start. We will update on how the 19 pandemic as affected operations for Volition's thus far, I would like to reiterate how proud I am with the way that our team has adapted to the different world. We bought that been and kept working at full speed during this whole time the fantastic efforts have put us in excellent position as we move towards the launch of our first products expected later this year. During the first quarter of 2020 we implemented contingency planning to protect the health and well-being of our employees with most